Immunogenicity Parameters of Cancer Patients Receiving the mRNA Vaccine BNT162b2 While Obtaining Radiotherapy: A Longitudinal Cohort Evaluation

Paul Thöne; Margot Egger; Marija Geroldinger-Simic; Harald Kindermann; Lukas Kocik; Nicola Karasek; Barbara Fischerlehner; Kurt Spiegl; Georg Gruber; Bernhard Aschacher; Benjamin Dieplinger; Martin Clodi; Hans Geinitz

doi:10.3390/vaccines12030275

Immunogenicity Parameters of Cancer Patients Receiving the mRNA Vaccine BNT162b2 While Obtaining Radiotherapy: A Longitudinal Cohort Evaluation

Paul Thöne
, Margot Egger
, Marija Geroldinger-Simic
, Harald Kindermann
, Lukas Kocik
, Nicola Karasek
, Barbara Fischerlehner
, Kurt Spiegl
, Georg Gruber
, Bernhard Aschacher
, Benjamin Dieplinger
, Martin Clodi
, Hans Geinitz

Clinical Research Institute for Cardiovascular and Metabolic Diseases

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	275
Number of pages	14
Journal	Vaccines
Volume	12
Issue number	3
DOIs	https://doi.org/10.3390/vaccines12030275
Publication status	Published - Mar 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Fields of science

302 Clinical Medicine

Access to Document

10.3390/vaccines12030275

Cite this

Thöne, P., Egger, M., Geroldinger-Simic, M., Kindermann, H., Kocik, L., Karasek, N., Fischerlehner, B., Spiegl, K., Gruber, G., Aschacher, B., Dieplinger, B., Clodi, M., & Geinitz, H. (2024). Immunogenicity Parameters of Cancer Patients Receiving the mRNA Vaccine BNT162b2 While Obtaining Radiotherapy: A Longitudinal Cohort Evaluation. Vaccines, 12(3), Article 275. https://doi.org/10.3390/vaccines12030275

@article{e20763304ba84ed1b0938316a52ef109,

title = "Immunogenicity Parameters of Cancer Patients Receiving the mRNA Vaccine BNT162b2 While Obtaining Radiotherapy: A Longitudinal Cohort Evaluation",

author = "Paul Th{\"o}ne and Margot Egger and Marija Geroldinger-Simic and Harald Kindermann and Lukas Kocik and Nicola Karasek and Barbara Fischerlehner and Kurt Spiegl and Georg Gruber and Bernhard Aschacher and Benjamin Dieplinger and Martin Clodi and Hans Geinitz",

year = "2024",

month = mar,

doi = "10.3390/vaccines12030275",

language = "English",

volume = "12",

journal = "Vaccines",

issn = "2076-393X",

number = "3",

}

Thöne, P, Egger, M, Geroldinger-Simic, M, Kindermann, H, Kocik, L, Karasek, N, Fischerlehner, B, Spiegl, K, Gruber, G, Aschacher, B, Dieplinger, B, Clodi, M & Geinitz, H 2024, 'Immunogenicity Parameters of Cancer Patients Receiving the mRNA Vaccine BNT162b2 While Obtaining Radiotherapy: A Longitudinal Cohort Evaluation', Vaccines, vol. 12, no. 3, 275. https://doi.org/10.3390/vaccines12030275

TY - JOUR

T1 - Immunogenicity Parameters of Cancer Patients Receiving the mRNA Vaccine BNT162b2 While Obtaining Radiotherapy: A Longitudinal Cohort Evaluation

AU - Thöne, Paul

AU - Egger, Margot

AU - Geroldinger-Simic, Marija

AU - Kindermann, Harald

AU - Kocik, Lukas

AU - Karasek, Nicola

AU - Fischerlehner, Barbara

AU - Spiegl, Kurt

AU - Gruber, Georg

AU - Aschacher, Bernhard

AU - Dieplinger, Benjamin

AU - Clodi, Martin

AU - Geinitz, Hans

PY - 2024/3

Y1 - 2024/3

UR - https://www.scopus.com/pages/publications/85188991521

U2 - 10.3390/vaccines12030275

DO - 10.3390/vaccines12030275

M3 - Article

C2 - 38543909

SN - 2076-393X

VL - 12

JO - Vaccines

JF - Vaccines

IS - 3

M1 - 275

ER -

Immunogenicity Parameters of Cancer Patients Receiving the mRNA Vaccine BNT162b2 While Obtaining Radiotherapy: A Longitudinal Cohort Evaluation

UN SDGs

Fields of science

Access to Document

Other files and links

Cite this